Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05393869 · ClinicalTrials.gov registry record · NA
Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 2,849
- Enrollment target
NCT05393869: Completed NA study, sponsored by Ohio State University Comprehensive Cancer Center.
NCT05393869 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 2,849 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (103% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05393869, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,849 participants
- Enrollment target
Study Summary
This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine effective communication of polytobacco use risk to at-risk LGBT young adults.
Primary Outcome
6 items measured on 5-point scale, 1 = Not at all and 5 = Very much * These messages were worth remembering. * These messages grabbed my attention. * These messages are powerful. * These messages are convincing. * These messages are meaningful. * These messages are informative. Responses were summed and averaged to create a scale for intention to quit (range from 1 - 5). Higher scores indicate a higher persuasive potential of the message.
Interventions
- OTHER Health communications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,849 participants |
| Start Date | 2021-04-14 |
| Est. Completion | 2022-11-14 |
| Phase | NA |
What the finished NCT05393869 record still lists
NCT05393869 is an interventional study that assigns participants to a tested intervention. Its 2,849 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (103% higher).
The record links to 0 conditions, and to 1 intervention - of which Health communications is the first listed.
NCT05393869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05393869 about?
NCT05393869 is a clinical study titled "Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults". This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportion...
What is the current status of trial NCT05393869?
This trial is currently completed. It is a NA study. The enrollment target is 2,849 participants. The study started on 2021-04-14. Estimated completion is 2022-11-14.
What interventions are being tested in trial NCT05393869?
The interventions under investigation include: Health communications (OTHER).
Who is sponsoring clinical trial NCT05393869?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05393869's enrollment target sits among peer trials
2,849 43rd of 2000 higher than 1,958 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06150781 · 2,842 participants
Aimovig Pregnancy Exposure Registry
- NCT06351085 · 2,869 participants · NA
Enhancing Lung Cancer Screening Through Human-Centered Intervention
- NCT05624450 · 2,870 participants · Phase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- NCT02273297 · 2,821 participants
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI